Despite prior work, a direct comparison of the labeling of progenitor cardiac stem cells (CPCs) using protamine-sulphate (PS)-conjugated or FuGENE-labeled perfluorocarbon nanoparticle labels (based on their respective cellular uptake mechanisms), and their capacity to achieve direct cardiac 19FMRI on the same animal species, is still lacking. We report herein improved in vivo cardiac 19FMRI performance for FuGENE-labeled compared to PS-labeled CPCs.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords